Lung dosimetry for inhaled radon progeny in smokers

Radiation Protection Dosimetry

Volumn 138, Issue 2, 2009, Pages 111-118

  Baias, Paul F ^a   Hofmann, Werner ^b   Winkler Heil, Renate ^b   Cosma, Constantin ^c   Duliu, Octavian G ^a  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b UNIVERSITY OF SALZBURG   (Austria)

^c BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

RADON DAUGHTER;

ADULT; ARTICLE; BRONCHUS; COMPARATIVE STUDY; EXPOSURE; HUMAN; INDOOR AIR POLLUTION; LUNG; MALE; METABOLISM; MUCOCILIARY CLEARANCE; RADIATION DOSE; RADIATION EXPOSURE; SMOKING;

ADULT; AIR POLLUTION, INDOOR; BRONCHI; HUMANS; INHALATION EXPOSURE; LUNG; MALE; MUCOCILIARY CLEARANCE; RADIATION DOSAGE; RADON DAUGHTERS; SMOKING;

EID: 77950248685     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncp183     Document Type: Article

References (73)

1. Beir, V. Health effects of exposure to low levels of ionising radiation. Report of the Committee on the Biological effects of Ionizing Radiation, National Academy of Sciences (Washington, DC: National Academy Press) (1990).
2. Beir, V. I. Health effects of exposure to radon. Report of the Committee on the Biological effects of Ionizing Radiation, National Research Council (Washington, DC: National Academy Press) (1999).
3. ICRP, Limits for inhalation of radon daughters by workers. ICRP Publication 32 (Oxford: Pergamon Press) (1981).
4. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 2000 Report to the General Assembly, New York (2000).
5. OECD/NEA, Dosimetry aspects of exposure to radon and thoron daughter products, Report to a Group of Experts of the Organization for Economic Cooperation and Development (OECD), Nuclear Energy Agency (NEA), (1983)
6. International Commission on Radiological Protection. Human respiratory tract model for radiological protection. ICRP Publication 66 (Oxford: Pergamon Press) (1994).
7. Hofmann, W. Dose calculations for the respiratory tract from inhaled natural radioactive nuclides as a function of age. Part II: basal cell dose distributions and associated lung cancer risk. Health Phys. 43, 31-44 (1982).
8. Haque, A. K. M. and Collinson, A. J. L. Radiation dose to the respiratory system due to radon and its daughter products. Health Phys. 13, 431-443 (1967).
9. Harley, N. H. and Pasternack, B. S. Alpha absorption measurements applied to lung dose from radon daughters, Health Phys. 23, 771-782 (1972).
10. Winkler-Heil, R., Hofmann, W., Marsh, J. and Birchall, A. Comparison of radon lung dosimetry models for the estimation of dose uncertainties. Radiat. Prot. Dosim. 127, 27-30 (2007).
11. Harley, N. H., Cohen, B. S. and Robbins, E. S. The variability in radon decay product bronchial dose. Environ. Int. 22, 959-964 (1996).
12. Marsh, J. W. and Birchall, A. Sensitivity analysis of the weighted equivalent lung dose per unit exposure from radon progeny. Radiat. Prot. Dosim. 87, 167-178 (2000).
13. Porstendorfer, J. Physical parameters and dose factors of the radon and thoron decay products. Radiat. Prot. Dosim. 94, 365-373 (2001).
14. Marsh, J. W. et al. Uncertainty analysis of the weighted equivalent lung dose per unit exposure to radon progeny. Radiat. Prot. Dosim. 102, 229-248 (2002).
15. Nikezic, D., Lau, B. M. F. and Yu, K. N. Comparison of dose conversion factors for radon progeny from the ICRP 66 regional model and an airway tube model of tracheo-bronchial tree. Radiat. Environ. Biophys. 45, 2 (2006).
16. Stather, J. W. Dosimetric and epidemiological approaches to assessing radon doses - can the differences be reconciled? Radiat. Prot. Dosim. 112, 487-492 (2004).
17. United States Environmental Protection Agency (EPA). Assessment of risks from radon in homes. Publication EPA 402-R-03-003 (Washington, DC: Office of Air and Radiation) (2003).
18. Crawford-Brown, D. J. Modeling the modification of the risk of radon-induced lung cancer by ETS, Risk Anal. 12, 4 (1992).
19. Winters, T. H. and Franza, J. R. Radioactivity in cigarette smoke, New Engl. J Med. 306(6), 364-365 (1982).
20. Sterling, T. D. and Poland, T. M. Smoking produced mucus and clearance of particulates in the lung. In: Proceedings of the 29th Symposion on Health and Environment, "Indoor Rn and Lung Cancers: Reality or Myth", part 1 (Richland: Batelle Press) pp. 263-275 (1999).
21. Brick, J. Handbook of the Medical Consequences of Alcohol and Drug Abuse (Binghamton, NY: The Haworth Press) 434 (2008), Chapter 13.
22. 210Pb in cigars. J. Radioanal. Nucl. Chem. 253, 129-133 (2002).
23. Martell, E. A. α-radiation dose at bronchial bifurcations of smokers from indoor exposure to radon progeny. Proc. Natl. Acad. Sci. USA 80, 1285-1289 (1983).
24. Monchaux, G. Contribution of animal experimental data for the risk assessment of exposure to radon decay products. In: The Natural Radiation Environment VII (Oxford: Elsevier) pp. 66-76 (2005).
25. Cross, F. T. and Monchaux, G. Risk assessment of radon health effects from experimental animal studies. A joint review of PNNL (USA) and CEACOGEMA (France) data. In: Indoor Radon Exposure and Its Health Consequences. Quest for the True Story of Environmental Radon and Lung Cancer (Tokyo: Kodansha Scientific Ltd.) pp. 85-105 (1999).
26. Koblinger, L. and Hofmann, W. Monte Carlo modeling of aerosol deposition in human lungs. Part I: Simulation of particle transport in a stochastic lung structure, J. Aerosol Sci. 21(5), 661-674 (1990).
27. Hofmann, W. and Koblinger, L. Monte Carlo modeling of aerosol deposition in human lungs. Part II: Deposition fractions and their sensitivity to parameter variations. J. Aerosol Sci. 21(5), 661-674 (1990).
28. Hofmann, W. and Sturm, R. Stochastic model of particle clearance in human bronchial Airways. J. Aerosol Med. 17, 73-89 (2004).
29. Sturm, R. and Hofmann, W. Stochastic modelling predictions for the clearance of insoluble particles from the tracheobronchial tree of the human lung. Bull. Math. Biol. 69, 395-415 (2007).
30. Hofmann, W., Menache, M. G., Crawford-Brown, D. J., Caswell, R. S. and Karam, L. R. Modeling energy deposition and cellular radiation effects in human bronchial epithelium by radon progeny alpha particles. Health Phys. 78, 377-393 (2000).
31. Hofmann, W., Koblinger, L. and Mohamed, A. Incorporation of biological variability into lung dosimetry by stochastic modelling techniques, Environ. Int. 22(Suppl. 1), 995-1003 (1996).
32. Koblinger, L. and Hofmann, W. Analysis of human lung morphometric data for stochastic aerosol deposition calculations. Phys. Med. Biol. 35, 541-556 (1985).
33. Cheng, K. H., Cheng, Y. S., Yeh, H. C., Guilmette, R. A., Simpson, S. Q., Yang, Y. and Swift, D. L. In vivo measurements of nasal airway dimensions and ultrafine aerosol deposition in the human nasal and oral airways. J. Aerosol Sci. 27, 785-801 (1996).
34. Cohen, B. S. and Asgharian, B. Deposition of ultrafine particles in upper airways. J. Aerosol Sci. 21, 789-797 (1990).
35. Ingham, D. B. Diffusion of aerosol from a stream flowing through a cylindrical tube. J. Aerosol Sci. 6, 125-132 (1975).
36. Yeh, H. C. and Schum, G. M. Models of human lung airways and their application to inhaled particle deposition. Bull. Math. Biophys. 42, 461-480 (1980).
37. National Research Council (NRC), Comparative Dosimetry of Radon in Mines and Homes (Washington, DC: National Academy Press) (2005)
38. Mercer, R. R., Russel, M. L. and Crapo, D. J. Radon dosimetry based on the depth distribution of nuclei in human and rat lungs. Health Phys. 61, 117-130 (1991).
39. Asgharian, B., Hofmann, W. and Miller, F. J. Mucociliary clearance of insoluble particles from the tracheobronchial airways of the human lung. J. Aerosol Sci. 32(6), 817-832 (2001).
40. Brenner, D. J. Radon: current challenges in cellular radiobiology. Int. J. Radiat. Biol. 61(1), 3-13 (1992).
41. Axelson, O. and Sundell, L. Mining, lung cancer and smoking. Scand. J. Work Environ. Health. 4(1), 46-52 (1978).
42. Sen, S. K. and Gowda, M. Bronchogenic carcinoma: the significance of histology. J. Natl. Med. Assoc. 62(1), 46-49 (1970).
43. The Health Consequences of Smoking. Chronic obstructive lung disease. A Report of the Surgeon General (1984).
44. The health consequences of smoking. Cancer and chronic lung disease at workplace. A report of Surgeon General (1985).
45. Kern Buckner, J., Ditchey, R. V., Good, J. T. Jr., Matthay, R. A., Morrison, D., Petty, T. L. and Smith, S. C. Jr. Dyspnea (Denver, Co: The Snowdrift Pulmonary Foundation, Inc.) (2001).
46. Hogg, J. C., Wright, J. L., Wiggs, B. R., Coxson, H. O., Opazo Saez, A. and Paré, P. D. Lung structure and function in cigarette smokers, Thorax 49(5), 473-478 (1994).
47. Martin, J., Tobin, M. D. and Tejvir, S. Breathing patterns 2. Diseased subjects, Chest 84, 286-294 (1983).
48. Bertram, J. F. and Rogers, A. W. The development of squamous cell metaplasia in human bronchial epithelium by light microscopic morphometry. J. Microsc. 123, 61-73 (1981).
49. Baldwin, F., Hovey, A., McEwen, T., O'Connor, R., Unruh, H. and Bowden, D. H. Surface to nuclear distances in human bronchial epithelium: relationships to penetration by Rn daughters. Health Phys. 60(2), 155-162 (1991).
50. Rubin, B. K., Ramirez, O., Zayas, J. G., Finegan, B. and King, M. Respiratory mucus from asymptomatic smokers is better hydrated and more easily cleared by mucociliary action. Am.Rev.Respir. Dis. 145(3), 545 (1992).
51. Wolff, R. K. Effects of airborne pollutants on mucociliary clearance. Environ. Health Perspect. 66, 223-237 (1986).
52. McCool, F. D. Global physiology and pathophysiology of cough. ACCP evidence-based clinical practice guidelines, Chest 129, 48-53 (2006).
53. Agnew, J. E., Lopez-Vidriero, M. T. and Pavia, D. Functional small airways defence in symptomless cigarette smokers. Thorax 41, 524-530 (1986).
54. Isawa, T., Teshima, H. T. and Ebina, A. Mucociliary clearance mechanism in smoking and non-smoking normal subjects. J. Nucl. Med. 25, 352-359 (1984).
55. Yergin, B., Goodman, R. M., Landa, J. F., Golinvaux, M. H. and Sackner, M. A. Effects of cigarette smoking on tracheal mucous velocity in young smokers with and without small airway obstruction. Am. Res. Respir. Dis. 115 (Suppl.), 183 (1977).
56. Yeates, D. B., Aspin, N., Levison, H., Jones, M. T. and Bryan, A. C. Mucociliary tracheal transport rates in man. J. Appl. Physiol. 39, 487-495 (1975).
57. Scherrer-Crosbie, M., Paul, M., Meignan, M., Dahan, E., Lagrue, G., Atlan, G. and Lorino, A. M. Pulmonary clearance and lung function: influence of acute tobacco intoxication and of vitamin E. J. Appl. Physiol. 81(3), 1071-1077 (1996).
58. Inoue, T. et al. Effect of Inhaled Furosemide on Lung Clearance of Technetium-99m-DTPA. J. Nucl. Med. 36, 73-77 (1995).
59. 99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and patients with sarcoidosis. Eur. J. Nucl. Med. Mol. Imaging 15(2), 71-77 (1989).
60. 99m Tc. albumin in smokers. Clin. Physiol. 17, 183-192 (1997).
61. Coote, K. N., Atherton, A., Sugar, H. C. and Danahay, R. H. Mucociliary clearance is enhanced in rat models of cigarette smoke and lipopolysacharideinduced lung disease. Exp. Lung Res. 30(1), 59-72 (2004).
62. Thurlbeck, W. M. Pathology of chronic airflow obstruction. In: Chronic obstructive pulmonary disease. Cherniak, N. S. Ed. (Philadelphia: W. B. Saunders) (1991).
63. Dye, J. A. and Adler, K. B. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 49, 825-834 (1994).
64. Vestbo, J. Epidemiological studies in mucus hypersecretion. In: Mucus Hypersecretion in Respiratory Disease (Series: Novartis Foundation Symposia) (2003).
65. Ide, G., Suntzeff, V. and Cowdry, E. V. A Comparison of the histopathology of traheal and bronchial epithelium of smokers and non smokers. Cancer 12(3), 473-484 (1959) (From the Wernse Cancer Research Laboratory, Washington).
66. Aubry, M. C., Wright, J. L. and Myers, J. The Pathology of smoking related lung disease. Clin. Chest Med. 21(1), 11-35 (2000).
67. Brack, T., Jubran, A. and Tobin, M. J. Dyspnea and decreased variability of breathing in patients with restrictive lung disease, Am. J. Resp. Crit. Care 165, 1260-1264 (2002).
68. Lucchini, R. E. et al. Increased VIP-Positive Nerve Fibers in the Mucous Glands of Subjects with Chronic Bronchitis. Am. J. Respir. Crit. Care 156(6), 1963-1968 (1997).
69. Groneberg, D. A. and Chung, K. F. Models of chronic obstructive pulmonary disease. Resp. Res. 5, 18 (2004).
70. IARC Chromium, nickel and welding. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49 (Lyon, International Agency for Research on Cancer) 257-445 (1990).
71. Tobin, M. J., Chadha, T. S., Jenouri, G., Birch, S. J., Gazeroglu, H. B. and Sackner, M. A. Breathing patterns. 2. Diseased subjects. Chest 84, 286-294 (1983).
72. Marsh, J. W., Birchall, A. and Davis, K. Comparative doismetry in homes and mines: estimation of K-factors. In: Proceedings of seventh Symposium - The Natural Radiation Environement, Rhodes, May 2002 (Amsterdam: Elsevier) pp. 290-298 (2005).
73. Fakir, H., Hofmann, W. and Aubineau-Laniece, I. Microdosimetry of radon progeny in tracheobronchial bifurcations. Radiat. Prot. Dosim. 117, 382-394 (2005).